Endocrinologic and Metabolic Drugs Advisory Committee; Notice of Meeting; Correction

---
identifier: "/us/fr/E8-23718"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Endocrinologic and Metabolic Drugs Advisory Committee; Notice of Meeting; Correction"
title_number: 0
title_name: "Federal Register"
section_number: "E8-23718"
section_name: "Endocrinologic and Metabolic Drugs Advisory Committee; Notice of Meeting; Correction"
positive_law: false
currency: "2008-10-07"
last_updated: "2008-10-07"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "E8-23718"
document_type: "notice"
publication_date: "2008-10-07"
agencies:
  - "Health and Human Services Department"
  - "Food and Drug Administration"
fr_citation: "73 FR 58603"
fr_volume: 73
docket_ids:
  - "Docket No. FDA-2008-N-0038"
fr_action: "Notice; correction."
---


#  Endocrinologic and Metabolic Drugs Advisory Committee; Notice of Meeting; Correction

**AGENCY:**

Food and Drug Administration, HHS.

**ACTION:**

Notice; correction.

**SUMMARY:**

The Food and Drug Administration is correcting a notice that appeared in the *Federal Register* of September 24, 2008 (73 FR 55114). The document announced a forthcoming meeting of a public advisory committee of the Food and Drug Administration (FDA). A portion of the meeting will be closed to the public. This document corrects the error.

**FOR FURTHER INFORMATION CONTACT:**

Theresa Green, Office of the Commissioner, Food and Drug  Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-1220.

**SUPPLEMENTARY INFORMATION:**

In FR Doc. E8-22437, appearing on page 55114 in the *Federal Register* of Wednesday, September 24, 2008, the following correction is made:

1. On page 55114, in the third column, in the *Procedure* section, the fourth sentence is corrected to read “Oral presentations from the public will be scheduled between approximately 2 p.m. and 3 p.m.”

There are no other changes to the document.

Dated: October 1, 2008.

Randall W. Lutter,

Deputy Commissioner for Policy.